Peter A. McSweeney

23.9k total citations
143 papers, 6.3k citations indexed

About

Peter A. McSweeney is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Peter A. McSweeney has authored 143 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Hematology, 47 papers in Oncology and 37 papers in Immunology. Recurrent topics in Peter A. McSweeney's work include Hematopoietic Stem Cell Transplantation (77 papers), Systemic Sclerosis and Related Diseases (18 papers) and Immune Cell Function and Interaction (16 papers). Peter A. McSweeney is often cited by papers focused on Hematopoietic Stem Cell Transplantation (77 papers), Systemic Sclerosis and Related Diseases (18 papers) and Immune Cell Function and Interaction (16 papers). Peter A. McSweeney collaborates with scholars based in United States, Germany and Italy. Peter A. McSweeney's co-authors include Rainer Storb, Brenda M. Sandmaier, David G. Maloney, Thomas R. Chauncey, Michael B. Maris, Barry E. Storer, Richard A. Nash, Benedetto Bruno, Karl G. Blume and Ute Hegenbart and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Peter A. McSweeney

141 papers receiving 6.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter A. McSweeney United States	44	3.9k	1.7k	1.6k	1.0k	938	143	6.3k
Álvaro Urbano-Ispizúa Spain	44	3.3k 0.8×	2.3k 1.3×	1.7k 1.1×	1.3k 1.2×	679 0.7×	215	6.1k
Donald Bunjes Germany	48	3.8k 1.0×	2.5k 1.4×	1.9k 1.2×	1.4k 1.4×	1.2k 1.2×	221	7.7k
Gabriela Rondón United States	41	4.7k 1.2×	2.1k 1.2×	2.3k 1.4×	1.2k 1.1×	586 0.6×	254	7.0k
Richard A. Nash United States	48	4.9k 1.2×	2.7k 1.6×	1.6k 1.0×	1.1k 1.1×	1.4k 1.5×	176	7.8k
Hans‐Jochem Kolb Germany	39	3.2k 0.8×	1.8k 1.1×	1.7k 1.1×	842 0.8×	593 0.6×	175	5.9k
Gregory A. Hale United States	40	2.5k 0.6×	1.3k 0.8×	1.5k 0.9×	801 0.8×	707 0.8×	133	5.3k
Benedetto Bruno Italy	51	5.5k 1.4×	2.1k 1.2×	2.6k 1.6×	1.3k 1.2×	843 0.9×	278	8.0k
Francesca Gualandi Italy	40	3.2k 0.8×	1.5k 0.9×	1.6k 1.0×	2.1k 2.0×	535 0.6×	129	6.1k
Hildegard Greinix Austria	47	5.6k 1.4×	2.6k 1.5×	1.9k 1.2×	1.2k 1.1×	609 0.6×	244	8.9k
Rainer Schwerdtfeger Germany	43	4.3k 1.1×	1.3k 0.8×	1.4k 0.8×	1.2k 1.2×	392 0.4×	126	6.0k

Countries citing papers authored by Peter A. McSweeney

Since Specialization

Citations

This map shows the geographic impact of Peter A. McSweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. McSweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. McSweeney more than expected).

Fields of papers citing papers by Peter A. McSweeney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. McSweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. McSweeney. The network helps show where Peter A. McSweeney may publish in the future.

Co-authorship network of co-authors of Peter A. McSweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. McSweeney. A scholar is included among the top collaborators of Peter A. McSweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. McSweeney. Peter A. McSweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wareing, Nancy, Xuan Wang, Ellen Goldmuntz, et al.. (2024). Myeloablation Followed by Hematopoietic Stem Cell Transplantation and Long‐Term Normalization of Systemic Sclerosis Molecular Signatures. Arthritis & Rheumatology. 76(8). 1288–1293. 3 indexed citations

O’Connor, Kevin C., Richard J. Nowak, Minh Pham, et al.. (2023). Remission of severe myasthenia gravis after autologous stem cell transplantation. Annals of Clinical and Translational Neurology. 10(11). 2105–2113. 1 indexed citations

Adamska, Julia Z., Amin Zia, Michelle S. Bloom, et al.. (2022). Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis. Annals of the Rheumatic Diseases. 82(3). 357–364. 11 indexed citations

Nash, Richard A., Ted Gooley, Tara Gregory, et al.. (2021). Non-Myeloablative Hematopoietic Stem Cell Transplantation (NMA HSCT) Utilizing Low-Dose Total Body Irradiation (TBI) Plus Fludarabine (Flu): A Comparison of Single-Center Based Flu 150 mg/m2 Plus 400 Cgy TBI Versus Flu 90 mg/m2 and 200 Cgy TBI Containing Regimens. Transplantation and Cellular Therapy. 27(3). S226–S227.

Dickinson, Michael, Nada Hamad, Christian Bryant, et al.. (2021). A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with B-Cell Malignancies. Blood. 138(Supplement 1). 3868–3868. 16 indexed citations

Wang, Michael, Javier Muñoz, André Goy, et al.. (2019). KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results of the Phase 2 ZUMA-2 Study. Blood. 134(Supplement_1). 754–754. 18 indexed citations

Laudenslager, Mark L., Teresa L. Simoneau, Susan K. Mikulich‐Gilbertson, et al.. (2019). A randomized control trial of stress management for caregivers of stem cell transplant patients: Effect on patient quality of life and caregiver distress. Psycho-Oncology. 28(8). 1614–1623. 30 indexed citations

Georges, George E., Peter A. McSweeney, James D. Bowen, et al.. (2018). Autologous Hematopoietic Stem Cell Transplantation May Be Highly Effective Treatment for Severe, Treatment Refractory Stiff Person Syndrome (S31.007). Neurology. 90(15_supplement). 4 indexed citations

Rotta, Marcello, Barry E. Storer, Firoozeh Sahebi, et al.. (2008). Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting. Blood. 113(14). 3383–3391. 71 indexed citations

10.

Sorror, Mohamed L., Barry E. Storer, Brenda M. Sandmaier, et al.. (2008). Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning. Journal of Clinical Oncology. 26(30). 4912–4920. 182 indexed citations

11.

Sullivan, K., D. H. Wallace, Peter A. McSweeney, et al.. (2008). Gastric antral vascular ectasia (GAVE) in early diffuse SSc: Report from the SCOT trial. Arthritis & Rheumatism. 58(9). 3 indexed citations

12.

Sorror, Mohamed L., Barry E. Storer, Brenda M. Sandmaier, et al.. (2008). Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation. Cancer. 112(9). 1992–2001. 199 indexed citations

13.

Maris, Michael B., Brenda M. Sandmaier, Barry E. Storer, et al.. (2006). Unrelated Donor Granulocyte Colony-Stimulating Factor–Mobilized Peripheral Blood Mononuclear Cell Transplantation after Nonmyeloablative Conditioning: The Effect of Postgrafting Mycophenolate Mofetil Dosing. Biology of Blood and Marrow Transplantation. 12(4). 454–465. 75 indexed citations

14.

Hegenbart, Ute, Dietger Niederwieser, Brenda M. Sandmaier, et al.. (2005). Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors. Journal of Clinical Oncology. 24(3). 444–453. 181 indexed citations

15.

Nieto, Yago, James J. Vredenburgh, Elizabeth J. Shpall, et al.. (2004). Phase II Feasibility and Pharmacokinetic Study of Concurrent Administration of Trastuzumab and High-Dose Chemotherapy in Advanced HER2+ Breast Cancer. Clinical Cancer Research. 10(21). 7136–7143. 12 indexed citations

16.

Parikh, Chirag R., Brenda M. Sandmaier, Rainer Storb, et al.. (2004). Acute Renal Failure after Nonmyeloablative Hematopoietic Cell Transplantation. Journal of the American Society of Nephrology. 15(7). 1868–1876. 61 indexed citations

17.

Sandmaier, Brenda M., David G. Maloney, Michael B. Maris, et al.. (2003). Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant. Biology of Blood and Marrow Transplantation. 9(4). 266–272. 21 indexed citations

18.

Parikh, Chirag R., Peter A. McSweeney, Didem Korular, et al.. (2002). Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney International. 62(2). 566–573. 109 indexed citations

19.

Maloney, DG, Ted Gooley, Ute Hegenbart, et al.. (2001). NONMYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTS (HSCT) FROM HLA-MATCHED RELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: CLINICAL RESULTS OF A TBI-BASED CONDITIONING REGIMEN. Blood. 742–743. 32 indexed citations

20.

Sandmaier, Brenda M., David G. Maloney, Peter A. McSweeney, et al.. (2001). Nonmyeloablative Hematopoietic Cell Transplantation. Annals of the New York Academy of Sciences. 938(1). 328–339. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact